disagree. Was overwhelming oversold previously. Market appreciate new guidance with solid growth from burns and soft tissue for well over 5 years. Progress over the last 3 quarters with increasing adoption. Japan going better than expected. Now not relying on barda revenue. Big upcoming fda approvals too. Clear communication from new leadership. Can go much higher in my opinion.
AVH Price at posting:
$3.60 Sentiment: Buy Disclosure: Held
